β³ Fetching live dividend data...
Home βΊ Calculator βΊ VTRLY Dividend Calculator 2026
Vitrolife AB (publ) Β· OTC
Price: $9.50 Β· Annual div: $0.12/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in VTRLY β $10.37M in 10 years Β· $10.47/month
Vitrolife AB (publ) is a Swedish medical technology company, established in 1994 and headquartered in Gothenburg. Its core business involves the development, manufacturing, and distribution of specialized products catering to assisted reproductive technologies (ART). The company offers a comprehensive portfolio that includes essential tools for the in vitro fertilization (IVF) process, such as oocyte retrieval needles, solutions for sperm preparation, and advanced IVF culture media and oils. Beyond these, Vitrolife supplies a range of laboratory necessities like micromanipulation pipettes, general labware, and various types of incubators, alongside products for cryopreservation and preimplantation genetic testing. A significant part of its offering comprises cutting-edge time-lapse systems, notably EmbryoScope and Primo Vision, complemented by specific dishes and analytical tools for embryo evaluation. The company also provides Octax laser and imaging systems, in addition to monitoring equipment such as log and guard systems with wireless sensors. Vitrolife operates on a global scale, serving markets across Europe, the Middle East, Africa, Asia, Japan, the Pacific region, and both North and South America. The firm adopted its current name in 1998, having previously been known as Scandinavian IVF Science.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open VTRLY position with:
Real after-tax yield depends on where you live and how you hold VTRLY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 1.24% | -1.56% | $124 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 1.05% | -1.75% | $105 / yr |
| πΊπΈ US Taxable (20%) | 20% | 0.99% | -1.81% | $99 / yr |
| π¬π§ UK ISA | 0% | 1.24% | -1.56% | $124 / yr |
| π¬π§ UK Taxable | 8.75% | 1.13% | -1.67% | $113 / yr |
| π¨π¦ TFSA | 0% | 1.24% | -1.56% | $124 / yr |
| π¨π¦ CA Taxable | 25% | 0.93% | -1.87% | $93 / yr |
| π¦πΊ Super (pension) | 15% | 1.05% | -1.75% | $105 / yr |
| π¦πΊ AU Taxable | 30% | 0.87% | -1.93% | $87 / yr |
| π©πͺ DE Taxable | 26.375% | 0.91% | -1.89% | $91 / yr |
| π«π· FR Taxable | 30% | 0.87% | -1.93% | $87 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.12/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
VTRLY pays quarterly β 4 times per year. Next ex-div: TBD.
How VTRLY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for VTRLY sourced from FMP /financial-growth endpoint β real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the VTRLY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Vitrolife AB (publ) (VTRLY) is currently trading at $9.50, trading near its 52-week low. The current dividend yield is 1.24% based on an annual payout of $0.12 per share.
Vitrolife AB (publ) (VTRLY) is a healthcare stock currently trading at $9.50 with a dividend yield of 1.24%. The company pays an annual dividend of $0.12 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever